Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 25 citing articles:

Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 78
Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
Nicola Lott, Caroline E. Gebhard, Susan Bengs, et al.
Nature Reviews Endocrinology (2022) Vol. 19, Iss. 4, pp. 217-231
Open Access | Times Cited: 27
Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control
Shen Wang, Wujian Li, Zhenshan Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Antiandrogens as Therapies for COVID-19: A Systematic Review
Massimiliano Cani, Samantha Epistolio, Giulia Dazio, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 298-298
Open Access | Times Cited: 4
Recent advances in small-molecular therapeutics for COVID-19
Lei Zhong, Zhipeng Zhao, Xuerun Peng, et al.
Precision Clinical Medicine (2022) Vol. 5, Iss. 4
Open Access | Times Cited: 21
Emerging small molecule antivirals may fit neatly into COVID-19 treatment
Caroline Fenton, Susan J. Keam
Drugs & Therapy Perspectives (2022) Vol. 38, Iss. 3, pp. 112-126
Open Access | Times Cited: 20
Antiandrogens for the treatment of COVID‐19 patients: A meta‐analysis of randomized controlled trials
Huzaifa Ahmad Cheema, Aqeeb Ur Rehman, Asmaa Ahmed Elrashedy, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 8
Proxalutamide for the treatment of COVID‐19 rebound following Paxlovid treatment: Report of four cases and review of the literature
Dawei Yang, Min‐Jie Ju, Hao Wang, et al.
Journal of Clinical Laboratory Analysis (2023) Vol. 37, Iss. 7
Open Access | Times Cited: 8
Higher premorbid serum testosterone predicts COVID-19-related mortality risk in men
Bu B. Yeap, Ross J. Marriott, Laurens Manning, et al.
European Journal of Endocrinology (2022) Vol. 187, Iss. 1, pp. 159-170
Open Access | Times Cited: 12
Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis
Jean Kim, Kyle Miyazaki, Parthav Shah, et al.
Healthcare (2022) Vol. 10, Iss. 4, pp. 645-645
Open Access | Times Cited: 10
Comparison of Preprint Postings of Randomized Clinical Trials on COVID-19 and Corresponding Published Journal Articles
Anthony D. Bai, Yunbo Jiang, David Nguyen, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2253301-e2253301
Open Access | Times Cited: 5
Medications Associated with Lower Mortality in a SARS-CoV-2 Positive Cohort of 26,508 Veterans
Christine M. Hunt, Jimmy T. Efird, Thomas S. Redding, et al.
Journal of General Internal Medicine (2022) Vol. 37, Iss. 16, pp. 4144-4152
Open Access | Times Cited: 8
A partially open conformation of an androgen receptor ligand-binding domain with drug-resistance mutations
S.K. Doamekpor, Panfeng Peng, Ruo Xu, et al.
Acta Crystallographica Section F Structural Biology Communications (2023) Vol. 79, Iss. 4, pp. 95-104
Closed Access | Times Cited: 3
Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response
Yuanyuan Qiao, Jesse W. Wotring, Yang Zheng, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 30
Open Access | Times Cited: 3
“MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale
Pierre Kory, G. Umberto Meduri, José Iglesias, et al.
Journal of Clinical Medicine Research (2022) Vol. 14, Iss. 2, pp. 53-79
Open Access | Times Cited: 5
Androgens’ Role in Severity and Mortality Rates of COVID-19
Ali Ataei, Mohammad Moein Derakhshan, Mohadese Razmjooie, et al.
Hormone and Metabolic Research (2022) Vol. 54, Iss. 12, pp. 813-826
Open Access | Times Cited: 5
Interventions reducing mortality in COVID-19 patients: a systematic review of randomized evidence
Nicolò Maimeri, Marilena Marmiere, Rosario Losiggio, et al.
Minerva Medica (2023) Vol. 115, Iss. 1
Closed Access | Times Cited: 1
Reply to Carlos G. Wambier and Gerard J. Nau’s Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–93. Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients
Karin Welén, Ebba Rosendal, Eva Freyhult, et al.
European Urology (2022) Vol. 81, Iss. 6, pp. e143-e144
Open Access | Times Cited: 2
Re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–93
Carlos Gustavo Wambier, Gerard J. Nau
European Urology (2022) Vol. 81, Iss. 6, pp. e141-e142
Open Access | Times Cited: 2
Effect of Androgen–Androgen Receptor Directed Therapy on COVID-19 Outcome in Prostate Cancer Patients
Serhan Ünlü, Junghee J. Shin, Jennefer Par‐Young, et al.
Cancer Investigation (2022) Vol. 41, Iss. 1, pp. 77-83
Closed Access | Times Cited: 1
Testosterone suppression combined with high dose estrogen as potential treatment of SARS-CoV-2. A mini review
Herjan J.T. Coelingh Bennink, Jan F M Egberts, F.M.J. Debruyne
Heliyon (2022) Vol. 8, Iss. 12, pp. e12376-e12376
Open Access | Times Cited: 1
Drug Repurposing Patent Applications October–December 2022
Hermann AM Mucke
Assay and Drug Development Technologies (2023) Vol. 21, Iss. 2, pp. 80-87
Closed Access
Androgen Drives the Expression of SARS-CoV-2 Entry Proteins in Sinonasal Tissue
Rong Rong Huang, Jenna M. Giafaglione, Takao Hashimoto, et al.
Journal of Clinical and Translational Pathology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access
Antiandrogen agents in COVID-19: a meta-analysis of randomized trials
Yuki Kotani, Giovanni Landoni, Tommaso Scquizzato, et al.
Minerva Medica (2023) Vol. 115, Iss. 1
Closed Access
Page 1

Scroll to top